Featuring interviews with Drs Bruce E Johnson and Thomas E Stinchcombe. (Audio Content)
OVERVIEW OF ACTIVITY
Traditional chemotherapy, surgery and radiation therapy have had a modest effect on long-term outcomes for patients with lung cancer. However, the advent of biologic and immunotherapeutic agents has led to recent improvements in disease-free and overall survival in select populations. In order to offer optimal patient care — including the option of clinical trial participation — clinicians must be well informed of these advances. Featuring information on the latest research developments, this program is designed to assist medical and radiation oncologists with the formulation of up-to-date strategies for the care of patients with lung cancer.
LEARNING OBJECTIVES
Featuring interviews with Drs Bruce E Johnson and Thomas E Stinchcombe. (Audio Content)